EXCL Stock Overview
Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Excellerant, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0006 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| EXCL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | -0.7% |
| 1Y | n/a | 0.6% | 22.8% |
Return vs Industry: Insufficient data to determine how EXCL performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how EXCL performed against the US Market.
Price Volatility
| EXCL volatility | |
|---|---|
| EXCL Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EXCL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EXCL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Roman Kopinski | excellerant.vc |
Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company intends to offer consulting services in the field of traditional and alternative medicine, and medical technologies; for customers to choose a clinic for treatment, as well as arrange the itinerary by building a route, which includes clinics, hospitals, and other medical institutions; and providing guide services to potential clients. Further, it provides information related to transportation and medical institutions.
Excellerant, Inc. Fundamentals Summary
| EXCL fundamental statistics | |
|---|---|
| Market cap | US$5.00 |
| Earnings (TTM) | -US$13.80k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs EXCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EXCL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$13.80k |
| Earnings | -US$13.80k |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EXCL perform over the long term?
See historical performance and comparison